These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 1789355)

  • 41. [Lipid metabolism in hormonal contraception].
    Manuilova IA; Dubnitskaia LV; Aleksandrovskaia TN; Shallaeva VV
    Akush Ginekol (Mosk); 1985 Aug; (9):51-4. PubMed ID: 2933983
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Effect of hormonal contraceptives on cardiovascular function].
    Manuilova IA; Dubnitskaia LV; Trutko NS
    Akush Ginekol (Mosk); 1983 Nov; (11):5-8. PubMed ID: 6364872
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Clinical data on the use of current oral contraceptives].
    Krymskaia ML; Khomasuridze AG
    Akush Ginekol (Mosk); 1983 Nov; (11):19-22. PubMed ID: 6666790
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Metrorrhagia caused by estrogen-progestin combinations].
    Erny R; Erny N
    Contracept Fertil Sex (Paris); 1994 Feb; 22(2):93-7. PubMed ID: 12319056
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Update on the metabolic effects of steroidal contraceptives.
    Sondheimer SJ
    Endocrinol Metab Clin North Am; 1991 Dec; 20(4):911-23. PubMed ID: 1778182
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Current perspectives on combination oral contraceptives.
    Smith MA; Youngkin EQ
    Clin Pharm; 1984; 3(5):485-96. PubMed ID: 6386284
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Oncological aspects of hormonal contraception].
    Bokhman IaV; Korkhov VV; Safronnikova NR
    Akush Ginekol (Mosk); 1981 Apr; (4):3-5. PubMed ID: 7018284
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Oral contraception: disadvantages of estrogen reduction].
    Denis C
    Contracept Fertil Sex (Paris); 1993 Jun; 21(6):481-8. PubMed ID: 12318238
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Potential advantages of triphasic combined oral contraceptives in the light of recent epidemiological and endocrinometabolic data].
    Gaspard U; Dubois M
    Contracept Fertil Sex (Paris); 1982 Sep; 10(9):551-60. PubMed ID: 12311606
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oral contraceptives: Pt. 2.
    Family Planning Association of New South Wales
    Fam Plann Inf Serv; 1978; 1(2):1-36. PubMed ID: 12338652
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency.
    Knopp RH; Walden CE; Wahl PW; Hoover JJ; Warnick GR; Albers JJ; Ogilvie JT; Hazzard WR
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Benefits and risks of hormonal contraception].
    Tscherne G
    Gynakol Geburtshilfliche Rundsch; 1992; 32(3):174-6. PubMed ID: 1467664
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Contraception without risk of breast disease: epidemiologic and physiopathologic arguments].
    Le Coutour X
    NPN Med; 1985 Apr; 5(88):471-6. PubMed ID: 12315304
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Canadian Contraception Consensus (Part 3 of 4): Chapter 7--Intrauterine Contraception.
    Black A; Guilbert E; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman W; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; Mansouri S
    J Obstet Gynaecol Can; 2016 Feb; 38(2):182-222. PubMed ID: 27032746
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Systemic changes during the use of hormonal contraceptives].
    Manuilova IA; Trutko NS; Dubnitskaia LV; Kuramshina AKh
    Akush Ginekol (Mosk); 1983 Nov; (11):14-7. PubMed ID: 6666789
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The third S.K. & F. Prize lecture, University of London, December 1981. The clinical pharmacology of oral contraceptive steroids.
    Orme ML
    Br J Clin Pharmacol; 1982 Jul; 14(1):31-42. PubMed ID: 7049209
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Cutaneous effects in hormonal contraception].
    Thomas P; Dalle E; Revillon B; Delecour M; Devarenne-nicolle MF; Pagniez I
    NPN Med; 1985 Jan; 5(81):19-24. PubMed ID: 12281276
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An update on the pill.
    Initiatives Popul; 1983; 7(3):2-15. PubMed ID: 12339841
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oral contraceptive type and functional ovarian cysts.
    Lanes SF; Birmann B; Walker AM; Singer S
    Am J Obstet Gynecol; 1992 Mar; 166(3):956-61. PubMed ID: 1550172
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Incidence of endometrial cancer in relation to the use of oral contraceptives.
    Weiss NS; Sayvetz TA
    N Engl J Med; 1980 Mar; 302(10):551-4. PubMed ID: 7351890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.